3 test combo to treat AD?

Share this article:

Combining diagnostic tests that include imaging and cerebrospinal fluid biomarkers can improve prediction of a patient progressing from mild cognitive impairment to Alzheimer's disease, according to a study published Dec. 11 in Radiology.

Duke Medicine researchers reviewed three tests — magnetic resonance imaging (MRI), fluorine 18 fluorodeoxyglucose positron emission tomography (FDG-PET), and cerebrospinal fluid analysis — to learn whether the trio were more accurate than single tests. The study subjects also were given routine clinical exams.

Share this article:
close

Next Article in News

More in News

$1.2 million awarded in case of nursing home resident trapped, fatally burned ...

A nursing home resident in Ohio suffered fatal burns from a radiator, leading to arbitration that ended last week with a $1.2 million award.

Common arthritis drug stopped Alzheimer's in its tracks, researchers say

An arthritis drug stopped the deterioration of cognitive functions and activities of daily living capabilities in Alzheimer's patients in a small trial, researchers from the University of Southampton in England recently announced.

House bill would give some long-term care providers a break from the employer mandate

House bill would give some long-term care providers ...

Certain long-term care providers would get a temporary break on Affordable Care Act requirements regarding employee insurance plans under a bill introduced in the House of Representatives.